Market Signal Briefing

The XRP price has plunged by over 35% from its highest point this year, and an emerging death cross pattern suggests further downside despite some notable bullish catalysts. 

Summary

XRP price has formed a death cross pattern on the daily chart.
This pattern points to more downside in the near term.
Still, Ripple has numerous bullish catalysts that may offset the drop.

XRP price technical analysis
The daily chart shows that the Ripple (XRP) token was trading at $2.3700 today, Oct. 19, up by 33% from its lowest point this month. This price coincides with the ultimate support of the Murrey Math Lines tool. 

Worse, the token has formed a death cross pattern, which could lead to more downside. This cross happens when the 50-day and 200-day Weighted Moving Averages cross each other when pointing downwards. It is one of the most bearish patterns in technical analysis. 

The XRP price remains below the key resistance level at $2.70, which marks the lower side of the descending triangle pattern. This is another highly popular bearish signs.

Ripple price has invalidated the impulse phase of the Elliot Wave pattern. Therefore, there is a risk that the coin will continue falling as sellers target the key psychological point at $2. 

XRP price chart | Source: crypto.news
Ripple has numerous bullish catalysts 
The bearish XRP price forecast is based on its technicals, as the coin has numerous bullish fundamentals. One of the fundamentals is the rumor that Ripple Labs was considering launching a $1 billion fund to accumulate XRP. 

Such a move would lead to more demand for the coin. Other companies like SBI Holdings, Trident Digital, Amber Power, VivoPower, and Webus have announced XRP treasuries. 

XRP will also benefit with the approval of spot XRP ETFs by the Securities and Exchange Commission, which will likely happen after the government shutdown ends. 

The existing XRP ETFs, including the recently launched REX-Osprey XRP ETF, have all seen substantial inflows. The XRPR ETF has accumulated over $88 million in inflows, while the XXRP fund has over $294 million in assets.

The XRP price will also benefit from Ripple Labs’ recent acquisitions. It recently bought GTreasury, a company that helps firms move money globally in a $1 billion. This marked its entry into the corporate treasury industry.

I'm excited for Ripple and GTreasury to help corporates move money around the world faster, cheaper, 24/7/365, and actively manage and grow their money through safe, more efficient solutions. It's the Ripple platform put to work at the global corporate scale. The opportunity to… https://t.co/eIDycyBRPj

— Monica Long (@MonicaLongSF) October 16, 2025

Ripple Labs acquired Rail in a $200 million deal as well as Hidden Road in a $1.25 billion deal. These acquisitions will help to create value for the XRP Ledger network. They will also help in the integration of the Ripple USD (RLUSD), its stablecoin.

Bitcoin (BTC) is currently testing critical support near $111,000 after failing to extend its recent all-time highs above $126,000. The world's largest cryptocurrency has shed nearly 9% on weekly charts, reflecting fading momentum amid broader market uncertainty, including renewed U.S.–China trade tensions.

Dogecoin (DOGE) may be preparing for a major rebound after weeks of sideways movement, according to crypto analyst Ali Martinez.

This outlook comes as the meme cryptocurrency shows signs of short-term strength. As of press time, DOGE was valued at $0.19, gaining over 5% in the past 24 hours, while on the weekly time frame, it is up 4%.

DOGE seven-day price chart. Source: Finbold
In an X post on October 18, Martinez noted that DOGE is trading within an ascending parallel channel that stretches back to early 2023. Dogecoin is currently hovering near the lower boundary of this channel, a region that has historically acted as a reliable launch pad for rallies.

DOGE price analysis chart. Source: TradingView
At the same time, the token is defending a key support area around $0.16, near the 0.618 Fibonacci retracement level. As long as this zone holds, bullish momentum could begin to build. The next immediate price barrier is $0.21, which must be breached for DOGE to confirm a recovery.

If upward momentum strengthens, the first major resistance lies at $0.29, a level where the price previously faced strong rejection and which aligns with the mid-range trendline of the channel. 

A successful breakout above that level could propel DOGE toward $0.45 in the medium term. Under a strong bullish scenario, Martinez suggested Dogecoin could even reach $0.86 by 2026 if it follows the upper trajectory of the channel.

Dogecoin looking at $1 
Meanwhile, the possibility of Dogecoin breaking out was also highlighted by prominent crypto analyst The Scalping Pro, who in an X post on October 19 pointed out that the token is showing signs of a bullish setup that could push it toward $1 sooner than expected.

His outlook noted a steady uptrend forming since early 2024, with price consolidating around $0.19 and maintaining higher lows within an ascending channel.

A projected rebound from current levels suggests a move through $0.40 and a potential breakout toward the upper resistance near $1.17 by 2026. 

If the trend holds, Dogecoin’s structure points to renewed momentum and investor confidence. A sustained move above key resistance could confirm the start of a major rally.

Featured image via Shutterstock

Japan is keen on establishing a framework to allow banks to buy and sell cryptocurrencies, including Bitcoin.

Summary

Japan’s FSA may let banks buy and hold Bitcoin and other cryptocurrencies.
New framework would impose strict risk rules on bank crypto holdings.
Banks could register as exchanges, expanding retail investor access.

The country’s Financial Services Agency is beginning deliberations on system changes that would allow banks to acquire and hold cryptocurrencies in the same manner as stocks and government bonds.

As per local reports, the matter will be discussed at an upcoming working group meeting of the Financial Services Council, an advisory body to the Prime Minister.

The FSA is expected to impose regulations accounting for the impact on banks’ financial stability, with discussions focusing on establishing risk management systems for cryptocurrency holdings.

Current restrictions show price volatility concerns
The FSA’s supervisory guidelines, revised in 2020, effectively prohibit bank groups from acquiring crypto assets for investment purposes.

The guidelines mentioned that holding large cryptocurrency amounts could result in losses during sudden price drops, potentially worsening a bank’s financial position.

Even if the acquisition and holding receive approval, the FSA is expected to impose strict regulations, considering the impact on banks’ financial status.

The working group will likely discuss establishing comprehensive risk management frameworks specific to cryptocurrency volatility and market dynamics.

Japan’s early embrace of cryptocurrency regulation provides a foundation for these more advanced policy discussions.

Exchange registration and retail access expansion
The FSA is considering allowing bank groups to register as cryptocurrency exchange operators. Permitting highly credible bank groups to participate would create an environment that makes it easier for individual investors to access cryptocurrency markets.

Cryptocurrency trading is expanding across Japan, with accounts exceeding 12 million as of February 2025. This is approximately 3.5 times the number from five years earlier.

Japan became the first major economy to recognize Bitcoin (BTC) as a legal payment method through the 2017 Virtual Currency Act amendments to the Payment Services Act.

The framework required cryptocurrency exchanges to register with the FSA and follow strict security, customer fund protection, and operational transparency rules.

The country’s early cryptocurrency adoption dates to 2010, when Japanese tech enthusiasts actively mined Bitcoin and traded on early exchanges.

Stablecoin update
Meanwhile, three of Japan’s largest banks—Mitsubishi UFJ Financial Group (MUFG), Bank Sumitomo Mitsui Banking Corp. (SMBC), and Mizuho Bank—are collaborating to issue a yen-pegged stablecoin to modernize corporate settlements and lower transaction costs.

The stablecoin will be built on MUFG’s Progmat platform and is expected to be rolled out by the end of the year.

The initiative, according to Nikkei, aims to make the token interoperable for payments within and between companies.

Mitsubishi Corp. will be the first to implement the stablecoin for internal settlements, potentially streamlining international transfers and reducing administrative costs. If successful, the project could launch Japan’s first bank-backed stablecoin network.

Japan is also considering a digital yen through the Bank of Japan’s (BOJ) pilot program, which began in 2023. Since then, the BOJ has been testing a central bank digital currency (CBDC) as part of a broader effort to modernize its economy alongside the evolving digital payments space.

As Japan continues to innovate within the cryptocurrency space, its regulatory framework plays a crucial role in shaping the industry’s growth. While private sector initiatives like the yen-pegged stablecoin project reflect the country’s push toward adoption, individual investors look to Japan’s FSA for answers on whether they’ll have easier access to cryptocurrency markets.

OpenSea, once the face of the NFT boom, is stepping into an entirely new era. CEO Devin Finzer has announced that the platform’s long-awaited SEA token will launch in the first quarter of 2026, marking a major shift from being a simple NFT marketplace to a multi-chain trading hub. Alongside the token rollout, OpenSea plans to integrate perpetual futures trading, expand into mobile, and pour half of its platform revenue into SEA token buybacks—a bold signal that the company is betting big on its onchain future.

The Long-Awaited SEA Token Is Finally ComingOpenSea’s CEO, Devin Finzer, confirmed that the platform’s native SEA token will officially launch in the first quarter of 2026. The announcement, made via X in collaboration with the OpenSea Foundation, marks a new chapter for the NFT marketplace as it evolves into a broader crypto trading platform.

Half of the total SEA token supply will go to the OpenSea community — specifically to OG users and participants in the rewards program. According to Finzer, both groups will be rewarded separately, ensuring long-term community engagement.

Given OpenSea’s mixed history — from centralization concerns and poor user support to allegations of insider trading and arbitrary account bans — delivering on its new promises is critical. The SEA token launch and platform overhaul can’t just be another headline; it must prove that OpenSea has learned from past missteps. This is its chance to rebuild credibility, restore trust, and show the community it can actually evolve — not just rebrand.

50% of Revenue Set for Token BuybacksIn an interesting twist, OpenSea plans to allocate 50% of its platform revenue to token buybacks “at launch.” This move suggests a strong focus on creating immediate market demand and price support for SEA.

The company has not yet revealed the total token supply or specific details about how individual allocations will be calculated. However, users will reportedly be able to stake their SEA tokens to back specific collections and favorite projects, adding a social and community-driven layer to the token economy.

From NFT Marketplace to Multi-Chain Trading PlatformOpenSea is no longer just an NFT trading site. The company is repositioning itself as a multi-chain crypto trading aggregator — a one-stop platform for everything from tokens and art to perpetual futures contracts.

This evolution comes during a resurgence in trading activity. October 2025 marked OpenSea’s best month in three years, with $1.6 billion in crypto trading volume and $230 million in NFT trades. Despite the overall market slowdown from 2021’s highs, OpenSea still commands around two-thirds of Ethereum’s NFT market.

Futures, Mobile App, and a Broader Onchain VisionThe upcoming token launch aligns with a series of new features. OpenSea plans to roll out perpetual futures trading — a feature that mirrors the growing popularity of “perps” on decentralized exchanges like Hyperliquid and Aster.

Meanwhile, its mobile app is currently in closed alpha testing, with a public release expected before the SEA token generation event. This signals OpenSea’s intent to capture a wider audience by integrating mobile-first and onchain-native experiences.

“Trade Everything”: Finzer’s Vision for the FutureDevin Finzer summed up the company’s ambition clearly: OpenSea aims to become “the destination for the onchain economy in its entirety.”

His vision? A platform where users can “trade everything — tokens, culture, art, ideas, the digital and the physical — all in one place that feels like a home, not a bank.”

If OpenSea delivers on that promise, its SEA token launch could mark not just a new phase for the company, but a redefining moment for how NFTs and crypto markets converge.

If OpenSea wants this transformation to stick, execution will matter more than ambition. The crypto community has a long memory, and many still recall the frustrations of sudden account freezes, high fees, and vague policies. The SEA token, buyback plan, and multi-chain expansion all sound promising — but real success will depend on how OpenSea delivers transparency, fairness, and reliability this time around. Only then can it reclaim its place as a trusted leader in the onchain economy.

Most income investors are used to waiting. They buy a dividend stock, mark the calendar, and collect a check every three months.

SummaryMatch Group is rated a buy due to strong cash flows, attractive valuation, and ongoing turnaround initiatives.MTCH's flagship app, Tinder, faces challenges, but Hinge's growth and Tinder's revitalization efforts aim to recapture Gen Z users and drive long-term recovery.The company boasts a nearly 10% buyback yield and even a fresh dividend, enhancing shareholder returns amid industry growth expectations.Risks include intense competition and potential failed turnaround, but long-term prospects and recent regulatory outcomes support a positive long-term outlook. Jonathan Kitchen/DigitalVision via Getty Images

Introduction & Financials Match Group (NASDAQ:MTCH) has the largest global portfolio of online dating services, with giant names such as Tinder and Hinge, as well as many niche-focused apps and websites. Right now, the stock is trading

Analyst’s Disclosure:I/we have a beneficial long position in the shares of MTCH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

SummaryiShares International Dividend Growth ETF is rated a hold due to portfolio flaws and the availability of superior alternatives like LVHI.IGRO's backward-looking dividend growth strategy lacks quality screens, resulting in higher volatility, sector/geographic concentration, and underperformance versus LVHI.LVHI outperforms IGRO on risk-adjusted returns, yield, and liquidity, making it a more compelling choice for global ex-US dividend exposure.IGRO's current positioning is not well-suited for the tense macro environment; better options exist for resilient income and risk mitigation. ismagilov/iStock via Getty Images

In the field of international (excluding the United States) equity exposure, for many investors based in the U.S., as this is mainly a way to get diversification against a portfolio relying too much on the U.S., defensive dividend strategies are

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Analyst’s Disclosure:I/we have a beneficial long position in the shares of FDUS, TRIN, KBDC, MSDL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

There's a lot to like about this energy stock.

In 1949, Interprovincial Pipe Line (IPL) Company began building the first pipeline for exporting oil from Canada to the U.S. Seventy-six years later, that company's pipelines transport around 65% of Canadian oil destined for the U.S. and 30% of crude oil produced in all of North America.

Never heard of IPL? That's understandable. The company changed its name to Enbridge (ENB -0.32%) in 1998.

I didn't know Enbridge's full history when I first initiated a position in its stock a few years ago. However, the more I learn about the company, the more I like it. Here are three reasons why I keep buying more Enbridge shares.

Image source: Getty Images.

1. I like the dividend
The thing I immediately think of when Enbridge's name comes up is the company's dividend. Simply put, I like everything about the dividend.

For one thing, Enbridge's forward dividend yield stands at 5.8%. That's a juicy yield that should grab the attention of any income investor. Even investors who aren't seeking income may be impressed by the fact that an initial investment of $10,000 in Enbridge at its initial public offering (IPO) in 1994 would now be worth nearly $184,000 -- thanks largely to reinvesting dividends.

I'm also impressed by Enbridge's dividend track record. The company has increased its dividend for 30 consecutive years. That's a streak I don't expect to end anytime soon, with Enbridge's continued free-cash-flow growth and its distributable cash-flow payout of between 60% and 70%.

2. Enbridge's business is steady and resilient
Maybe I'm just being paranoid, but I have a feeling the stock market is poised for a major downturn. Valuations are at historical highs. The full impact of tariffs probably still hasn't been felt by the economy. Inflation is still weighing on consumers.

While I invest for the long term and have always resisted the urge to sell in panic when the stock market tanks, I'm highly selective about which stocks I buy with the current dynamics. Enbridge's steady and resilient business makes it easier for me to buy more shares.

The Trump administration has exempted Canadian oil and gas imports from tariffs, so that's not an issue for Enbridge. Around 80% of the company's earnings before interest, taxes, depreciation, and amortization (EBITDA) is protected from inflation. Enbridge has minimal exposure to commodity prices.

The company's acquisitions in recent years have made its cash flows even more reliable. Enbridge is now the largest natural gas utility in North America based on volume. The bottom line is that the underlying business behind this stock is both predictable and safe.

3. The company's growth prospects are solid
A dividend stock that can be described as steady and resilient usually doesn't deliver sizzling growth. I don't expect Enbridge to be another Nvidia. However, the company's growth prospects are solid. And the same artificial intelligence (AI) tailwind at Nvidia's back should also help Enbridge.

The data centers that host AI applications consume massive amounts of power. As agentic AI and other new uses of the technology gain widespread adoption, the demand for electricity will almost certainly increase significantly.

Roughly 43% of U.S. electricity was generated by natural gas in 2023, according to the U.S. Energy Information Administration. Another 16% was generated from coal-powered plants. But a major switch from coal to natural gas is underway. This is great news for Enbridge.

The company foresees around $50 billion of growth opportunities through 2030. That's nearly equal to the amount of revenue it made last year. Unsurprisingly, almost half of those growth opportunities ($23 billion) are in Enbridge's gas transmission business.

Again, I don't predict that Enbridge will deliver the kind of growth that will knock the socks off investors. However, I think the stock will produce double-digit percentage total returns over the long run with its attractive dividend included. That's enough reason for me to want to keep buying shares of this amazing dividend stock.

Keith Speights has positions in Enbridge. The Motley Fool has positions in and recommends Enbridge and Nvidia. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in FIX over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Regulations 33(c)-(d) of the Securities Regulations (Periodic and Immediate Reports), 1970

, /PRNewswire/ -- Max Stock Limited (TASE: MAXO) (the "Company") today announced holdings of interested parties and senior officers as of September 30, 2025:

A. Corporation's interested parties (including the CEO and directors, and including any other employee holding 5% or more of the corporation's issued share capital or voting rights):

Holder no.

Holder's Name

Name, class and series of security

Updated no. of securities

% holdings

% equity      % voting

% holdings (on a fully diluted basis)

% equity % voting

1

Moose Holdco Ltd.

Max Stock Ordinary Share

31,558,386

22.60           22.60

22.43            22.43

2

Ori Max

Max Stock Ordinary Share

24,981,492

17.89           17.89

17.76            17.76

3

Y.D. More Investments Ltd. (mutual funds)

Max Stock Ordinary Share

2,704,195

1.94             1.94

1.92              1.92

4

More Provident Funds and Pension Ltd. (provident funds)

Max Stock Ordinary Share

11,967,728

8.57             8.57

8.51              8.51

5

Max Stock Ltd.

Max Stock Ordinary Share

3,658,971

0.00             0.00

0.00              0.00

6

Migdal Holdings Insurance & Finance Ltd – Profit sharing life insurance policies

Max Stock Ordinary Share

14,574,051

10.44           10.44

10.36            10.36

7

Migdal Holdings Insurance & Finance Ltd. – Mutual funds management companies

Max Stock Ordinary Share

2,891,471

2.07             2.07

2.06              2.06

8

G. Gissin Advocates

Max Stock Ordinary Share

55,022

0.04             0.04

0.04              0.04

% holdings

% equity    % voting

% holdings (on a fully diluted basis)

% equity   % voting

63.55          63.55

63.08                63.08

B. Corporation's senior officers (excluding the CEO and directors, and excluding any other employee holding 5% or more of the corporation's issued share capital or voting rights):

Presented below is a summary table of the holdings of the corporation's senior officers:

Holder no.

Holder's Name

Name, class and series of security

Updated no. of securities

% holdings

% equity      % voting

% holdings (on a fully diluted basis)

% equity % voting

9

Shlomo Cohen

Max Stock Op2020 share options

100,195

0                      0

0.07      0.07

10

Nir Dagan

Max Stock Op2020 share options

28,987

0                      0

0.02      0.02

11

Shahar Kanizo

Max Stock Op2020 share options

23,619

0                      0

0.02      0.02

12

Ofir Edri

Max Stock Op2020 share options

84,326

0                      0

0.06      0.06

% holdings

% equity    % voting

% holdings (on a fully diluted basis)

% equity   % voting

0                      0

0.17          0.17

The summary table below includes an overview of interested party holdings which were subject to a change in the reporting period:

Name

Balance in previous report

(30-Jun-2025)

Change (+/-)

Maximal holding in period (%)

Minimal holding in period (%)

Comments

Y.D. More Investments Ltd.

2,362,904

+341,291

1.97 %

1.39 %

(*) Y.D. More Investments Ltd. ("More Investments") holds more than 5% of Max Stock's share capital through the mutual funds and provident funds managed by More Investments. More Investments is a public company jointly owned by Messrs. Eli Levi, Yosef Levi, Michael Meirov, Dotan Meirov, Binyamin Meirov and Yosef Meirov.

More Provident Funds & Pension Ltd.

12,066,976

-99,248

8.65 %

8.57 %

See above.

Migdal Insurance & Financial Holdings Ltd. – Life insurance accounts participating in profits

9,600,229

+4,973,822

10.44 %

6.88 %

(*) Migdal Insurance & Financial Holdings Ltd. ("Migdal") holds more than 5% of Max Stock's share capital through the mutual funds and provident funds managed by the Migdal corporate group. Migdal is a public company which is ultimately controlled by Mr. Shlomo Eliyahu (45.50%).

Migdal Holdings Insurance & Finance Ltd. – Mutual funds management companies

1,850,609

1,040,862

2.07 %

1.31 %

See above.

Guy Gissin Advocates

44,622

+10,400

Guy Gissin Advocates is jointly owned by one of the Company's directors, Mr. Guy Gissin and his wife Ms. Sigal Gissin Russak.

Shlomo Cohen

102,695

-2,500

Exercise of employee options.

Nir Dagan

48,987

-20,000

Exercise of employee options.

Ofir Edri

94,326

-10,000

Exercise of employee options.

(*) As notified to the Company by the interested party or to the best of the Company's knowledge.

This is an English translation of segments of a Hebrew immediate report that was published on October 19, 2025 (Ref. No. 2025-01-076699) (hereinafter: the "Hebrew Version"). This English version is only for convenience purposes. This is not an official translation and has no binding force. Whilst reasonable care and skill have been exercised in the preparation hereof, no translation can ever perfectly reflect the Hebrew Version. In the event of any discrepancy between the Hebrew Version and this translation, the Hebrew Version shall prevail.

About Max Stock
Max Stock is Israel's leading extreme value retailer, currently present in 64 locations throughout Israel. We offer a broad assortment of quality products for customers' everyday needs at affordable prices, helping customers "Dream Big, Pay Small". For more information, please visit https://ir.maxstock.co.il       

Company Contacts:
Talia Sessler,
Chief Corporate Development and IR Officer
[email protected]

SOURCE Max Stock Limited

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Range Financial Group LLC fully exited its position in Fortinet (FTNT 0.45%), selling 29,944 shares for an estimated $3.2 million, according to an SEC filing dated Oct. 17.

The fund sold its entire position in Fortinet.

The position previously accounted for 1.2% of the fund’s AUM

What happenedAccording to a filing with the Securities and Exchange Commission dated October 17, 2025, Range Financial Group LLC sold its entire stake in Fortinet. The firm liquidated the 29,944 shares it held, with the estimated value of the transaction based on the quarterly average price totaling $3.2 million. The fund now holds no position in Fortinet.

What else to knowThe fund sold out of Fortinet, reducing its exposure from 1.2% of AUM as of June 30, 2025 to zero

Top holdings after the filing:

NYSEMKT: GJAN: $13.9 million (5.0% of AUM) as of Sept. 30

NASDAQ: NVDA: $10 million (3.6% of AUM) as of Sept. 30

NASDAQ: STX: $7.7 million (2.8% of AUM) as of Sept. 30

NYSEMKT: SPLG: $7.2 million (2.6% of AUM) as of Sept. 30

NYSEMKT: PJAN: $7.1 million (2.6% of AUM) as of Sept. 30

Shares of Fortinet closed at $83.44 on Oct. 17, 2025, up 3.2% over the past year but underperforming the S&P 500's total return by 12.4 percentage points

Company overviewMetricValueMarket Capitalization$63.94 billionRevenue (TTM)$6.34 billionNet Income (TTM)$1.94 billionPrice (as of market close 10/17/25)$83.44Company snapshotFortinet, Inc. is a global provider of integrated cybersecurity solutions, offering a broad product portfolio and scalable security infrastructure. The company leverages a mix of proprietary hardware and software to deliver robust network protection and threat mitigation for enterprises of all sizes.

It serves a diverse global customer base across telecommunications, technology, government, financial services, education, retail, manufacturing, and healthcare sectors.

The company generates revenue primarily through hardware and software sales, security subscriptions, technical support, and professional services, leveraging a channel partner distribution model alongside direct sales.

Foolish takeRange Financial sold its entire position after adding shares during the second quarter. During the June 30 through Sept. 30 period, the fund boosted its share ownership from 2.7 million shares to nearly 3.2 million shares.

However, the share sale follows the market's negative reaction following Fortinet's second-quarter earnings release on Aug. 6, sending the share price down nearly 22% the following day.

The company reported a 14% revenue increase to over $1.6 billion, the high end of management's quarterly guidance. The company also reported adjusted diluted earnings per share of $0.64, exceeding its budgeted figure. Management also raised its annual EPS guidance.

Nonetheless, investors focused on Fortinet's announcement that it has completed 40% to 50% of its planned firewall upgrade cycle. The higher-than-expected figure led to concern that many customers have already upgraded, limiting future revenue growth. Several analysts downgraded their ratings following the announcement.

GlossaryAUM (Assets Under Management): The total market value of investments managed by a fund or investment firm.
Liquidated: Sold off an entire investment position, converting it to cash.
Exposure: The proportion of a portfolio invested in a particular asset, sector, or market.
Channel partner distribution model: A sales approach where products are sold through third-party partners rather than directly to customers.
Stake: The amount of ownership or shares held in a company or investment.
Quarterly average price: The average price of a security over a three-month reporting period.
Reportable U.S. equity assets: U.S. stock holdings that must be disclosed in regulatory filings.
TTM: The 12-month period ending with the most recent quarterly report.
Security subscriptions: Ongoing service contracts providing access to cybersecurity updates and support.
Centralized management: A system that allows control and monitoring of multiple devices or services from a single platform.
Endpoint protection: Security solutions designed to protect devices like computers and smartphones from cyber threats.
Threat mitigation: Actions or technologies used to reduce or prevent cybersecurity risks.

Lawrence Rothman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Fortinet and Nvidia. The Motley Fool has a disclosure policy.

Top U.S. Marijuana Stocks to Watch in October 2025
The U.S. cannabis industry continues to show remarkable strength as legalization momentum grows nationwide. Analysts project the market will exceed $45 billion by 2025, reflecting strong consumer demand and expanding state-level access. In addition, the cannabis sector supports over 400,000 full-time jobs and contributes billions in tax revenue each year. Recent headlines suggest the federal government may soon revisit reclassification, fueling optimism among investors and operators alike. As states add dispensaries and loosen regulations, top marijuana companies with strong retail networks and brand recognition are well-positioned for growth. Therefore, investors are closely watching U.S. marijuana stocks this week as industry sentiment improves and market catalysts align.

Moreover, traders are using both technical and fundamental analysis to navigate this volatile space effectively. Technical indicators such as moving averages, Fibonacci levels, and volume spikes help identify ideal entry and exit points. However, discipline and proper risk management remain crucial when trading cannabis stocks, given their frequent price swings. Setting stop-loss orders and keeping position sizes small can protect against sudden reversals. By combining technical signals with strong fundamentals and awareness of policy trends, investors can balance opportunity and risk. With that approach, traders are focusing on the top-performing U.S. marijuana stocks in October 2025, including Trulieve Cannabis Corp. (TCNNF), Curaleaf Holdings, Inc. (CURLF), and Green Thumb Industries Inc. (GTBIF).

[Read More] Cannabis Industry 2025: Growth, Regulation, and Green Market Momentum

Top U.S. Marijuana Stocks to Watch in October 2025

Trulieve Cannabis Corp. (OTC: TCNNF)
Curaleaf Holdings, Inc. (OTC: CURLF)
Green Thumb Industries Inc. (OTC: GTBIF)

Trulieve Cannabis Corp. (TCNNF)
Trulieve Cannabis Corp. remains one of the most dominant U.S. multi-state operators. Headquartered in Florida, the company operates more than 190 dispensaries across 11 states, with its largest presence in Florida, Pennsylvania, and Arizona. Its vertically integrated model gives it control from cultivation to retail, allowing it to maintain consistent product quality and brand strength. Trulieve continues to expand strategically through acquisitions and organic growth, cementing its reputation as a leader in the southeastern cannabis market. The company’s deep roots in Florida—where it commands the majority market share—position it to benefit heavily from the state’s medical and emerging adult-use segments. As more states consider full legalization, Trulieve’s extensive infrastructure and loyal customer base provide a strong foundation for long-term expansion across the U.S.

Financially, Trulieve reported stable performance in 2025 despite ongoing price compression across the cannabis industry. The company’s second-quarter results showed revenue near $290 million, driven primarily by retail growth in Florida and Pennsylvania. Its gross profit margin remained healthy at approximately 50%, supported by efficient cultivation and distribution operations. Trulieve also reported a net income improvement compared to the previous year, highlighting its disciplined cost management strategy. Additionally, the company reduced long-term debt, strengthening its balance sheet and operational flexibility. As margins stabilize and new adult-use markets open, Trulieve’s profitability outlook appears increasingly favorable. For investors, Trulieve stands out as a well-managed operator capable of balancing growth with sustainable returns amid a rapidly evolving industry landscape.

[Read More] 3 Marijuana Stocks To Start Your Cannabis Investing Journey

Curaleaf Holdings, Inc. (CURLF)
Curaleaf Holdings, Inc. continues to hold one of the largest retail footprints in the U.S. cannabis sector. The company operates in over 17 states with more than 150 dispensaries nationwide. Its biggest market remains Florida, where expansion and patient enrollment continue to grow steadily. Curaleaf’s vertically integrated model includes cultivation, processing, and distribution, allowing it to deliver consistent product lines under multiple brands. Moreover, the company’s presence extends internationally, giving it exposure to early-stage European markets and diversified growth potential. Curaleaf’s scale, brand recognition, and operational efficiency make it one of the most influential players in the U.S. cannabis industry heading into late 2025.

In its most recent quarterly report, Curaleaf posted revenue of roughly $310 million, reflecting steady performance despite market headwinds. The company maintained a gross margin near 50%, a sign of improving cost control and product mix optimization. Although total revenue declined modestly year over year, profitability and cash flow continued to strengthen. Curaleaf also narrowed its net losses as part of its ongoing restructuring plan and enhanced capital efficiency. Management’s focus on high-performing states and premium product categories has contributed to margin resilience even in competitive markets. With expanding brand partnerships and operational streamlining, Curaleaf is positioning itself for a stronger recovery as federal reform discussions gain traction in Washington.

[Read More] 3 Of The Best Cannabis Stocks In The Entire Sector To Know About

Green Thumb Industries Inc. (GTBIF)
Green Thumb Industries Inc. remains a standout among top-tier U.S. cannabis operators. The company runs more than 90 dispensaries across 15 states, with major retail strength in Illinois, Pennsylvania, and Florida. Its Rise and Essence retail brands continue to attract loyal customers, while its branded product portfolio dominates in multiple state markets. Green Thumb’s strategic mix of retail expansion and wholesale distribution provides a balanced growth model. Additionally, the company’s management team has maintained a disciplined approach, emphasizing profitability and organic growth rather than aggressive acquisitions. With strong positioning in high-demand states, Green Thumb continues to expand its retail presence methodically, adapting to market conditions while maintaining brand consistency.

Financially, Green Thumb has shown consistent revenue growth throughout 2025, reaching nearly $305 million in its latest quarter. The company reported gross margins around 52%, supported by strong retail performance and efficient cultivation practices. Net income improved compared to the previous year, marking one of the few profitable quarters among major U.S. operators. Green Thumb also maintained a solid cash position, allowing it to reinvest in new markets without diluting shareholders. Furthermore, management’s focus on maintaining low debt levels and expanding high-margin product categories underscores the company’s long-term strategy. As the U.S. moves closer to broader federal reform, Green Thumb’s operational discipline and strong brand portfolio make it one of the most resilient and promising cannabis stocks to watch this month.

[Read More] 3 Cannabis REITs Leading the Marijuana Stock Market in October 2025

A Rapidly Expanding Market
In conclusion, the U.S. cannabis sector continues to evolve rapidly, with leading operators like Trulieve, Curaleaf, and Green Thumb driving innovation and expansion. With legalization discussions gaining momentum and market fundamentals improving, these companies offer strong potential for growth. However, traders should remain disciplined, applying technical analysis for timing and risk management to safeguard capital while seizing opportunities in this dynamic industry.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | [email protected]

SummaryBE Semiconductor Industries is a key player in die-attach and packaging equipment, critical for advanced chip manufacturing.BESIY benefits from AI-driven chip demand and leads in advanced die attach but faces cyclicality and recent revenue softness.Despite weak near-term guidance and high valuation, BESIY is poised for significant growth from 2026-2028 as advanced packaging demand accelerates.Given its leadership in a niche market and enabling role for AI chips, I rate BESIY a buy, expecting upside as growth inflects.Looking for a helping hand in the market? Members of The Aerospace Forum get exclusive ideas and guidance to navigate any climate. Learn More » SweetBunFactory/iStock via Getty Images

The semiconductor sector remains red-hot, powered by data center expansion and accelerating AI adoption. While most investors focus on chip designers and foundries, equipment suppliers are another critical growth engine in the semiconductor value chain. One company flying under

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our partner, Akeso, Inc. (HKEX Code: 9926.HK), featuring the novel, potential first-in-class investigational bispecific antibody, ivonescimab. The data was presented today as part of the Presidential Symposium at the European Society for Medical Oncology 2025 Congress (ESMO 2025) in Berlin, Germany. The.

Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan) data from the Phase III PSMAddition trial in a Presidential Symposium at the European Society for Medical Oncology (ESMO) Congress 2025.

Pluvicto plus standard of care (SoC) (androgen receptor pathway inhibitor [ARPI] + androgen deprivation therapy [ADT]) demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS), reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI: 0.58, 0.90) versus SoC alone in patients with prostate-specific membrane antigen (PSMA)+ metastatic hormone-sensitive prostate cancer (mHSPC)1.

Results also show an early positive trend in overall survival (OS) in patients treated with Pluvicto plus SoC (HR 0.84; 95% CI: 0.63, 1.13); follow-up will continue until data are mature1. More patients achieved a complete response versus SoC alone (57.1% vs. 42.3%) and the overall response rate (ORR) was numerically higher in the Pluvicto plus SoC arm (85.3% vs. 80.8%)1. Pluvicto delayed time to progression to metastatic castration-resistant prostate cancer (mCRPC) (HR 0.70; 95% CI: 0.58, 0.84)1. The rPFS benefit was consistent across pre-specified subgroups1.

“In metastatic prostate cancer, choosing the most efficacious treatment early is crucial, even at initial diagnosis,” said Scott T. Tagawa, MD, a professor of medicine at Weill Cornell Medicine and a medical oncologist at NewYork-Presbyterian/Weill Cornell Medical Center. “These findings suggest that combining 177Lu-PSMA-617 with standard of care hormonal therapy offers patients more time without disease progression, a safety profile with adverse events that are most often low grade and managed with supportive care, and an encouraging trend in overall survival.”

“These results reinforce the potential for Pluvicto, a radioligand therapy that delivers treatment directly to target cells, to change how we treat metastatic prostate cancer,” said Shreeram Aradhye, President, Development and Chief Medical Officer, Novartis. “With significant benefit now shown across multiple disease stages, Pluvicto is redefining the standard of care. The strength of these results reflects our deep commitment to patients with prostate cancer and our leadership in radioligand therapy.”

The safety profile and tolerability of Pluvicto were consistent with its established profile in PSMAfore and VISION1,4,5. Grade ≥3 adverse events (AEs) were reported in 50.7% of patients in the Pluvicto plus SoC arm, compared to 43% on SoC alone1. The most common all-grade AEs were dry mouth, fatigue, nausea, hot flush and anemia1.

PSMAddition marks the third positive Phase III trial with Pluvicto1,4,5. Building on the significant benefit demonstrated in PSMAfore, which led to the US Food and Drug Administration (FDA) approval in pre-taxane mCRPC in March 2025, these new results strengthen the evidence base for Pluvicto and demonstrate its potential to improve outcomes in an even earlier stage of metastatic prostate cancer1,4,6. Novartis plans to submit these data to regulatory authorities before end of year.

About unmet need in mHSPC
Approximately 172,000 men are diagnosed with mHSPC each year across the US, China, Japan, France, Germany, Italy, Spain and the United Kingdom1. Most patients progress to mCRPC, typically within 20 months2,3,7,8. Progression to mCRPC is associated with significantly worse outcomes, including increased patient burden, worse quality of life and life expectancy less than two years9,10. More than 80% of patients with prostate cancer highly express the PSMA biomarker, making it a promising therapeutic target11-15.

About PSMAddition
PSMAddition (NCT04720157) is a Phase III, open-label, prospective, 1:1 randomized study comparing the efficacy and safety of Pluvicto in combination with SoC (ARPI + ADT) vs. SoC alone in adult patients with PSMA+ mHSPC16. The primary endpoint is rPFS, defined as the time to radiographic progression by PCWG3-modified RECIST V1.1 (as assessed by BIRC) or death16. The key secondary endpoint of OS is defined as time to death due to any cause16. The study remains ongoing and a total of 1,144 patients with mHSPC across 20 countries have been randomized in the trial16.

About Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan)
Pluvicto is an intravenous RLT that combines a targeting compound (a ligand) with a therapeutic radionuclide (a radioactive particle, in this case lutetium-177)5,17. After administration into the bloodstream, Pluvicto binds to PSMA-expressing target cells, including prostate cancer cells that express PSMA, a transmembrane protein5,17. Once bound, energy emissions from the radioisotope damage the target cells and nearby cells, disrupting their ability to replicate and/or triggering cell death17.

Pluvicto is the only PSMA-targeted agent approved for PSMA+ mCRPC and is the first RLT to demonstrate a clinical benefit for patients with PSMA+ mHSPC in a Phase III trial1. Novartis is investigating Pluvicto in oligometastatic prostate cancer, an earlier stage of disease, in the PSMA-DC trial (NCT05939414).

Novartis and radioligand therapy (RLT)
Novartis is reimagining cancer care with RLT for patients with advanced cancers. By harnessing the power of targeted radiation and applying it to advanced cancers, RLT is designed to deliver treatment directly to target cells, anywhere in the body18,19. Novartis is investigating a broad portfolio of RLTs, exploring new isotopes, ligands and combination therapies to look beyond gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and prostate cancer and into breast, colon, lung and pancreatic cancer. Novartis has established global expertise, with specialized supply chain and manufacturing capabilities across its network of RLT production sites. To support growing demand for RLTs, we have active production capabilities in Millburn (NJ), Zaragoza (Spain), Ivrea (Italy) and a state-of-the-art facility in Indianapolis (IN). Expansions are ongoing in Carlsbad (CA), where Novartis is establishing its third US-based RLT manufacturing site to support expanded use of RLTs, and Sasayama (Japan) to create resiliency and optimize delivery of medicines to patients.

Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “potential,” “can,” “will,” “plan,” “may,” “could,” “would,” “expect,” “anticipate,” “look forward,” “believe,” “committed,” “investigational,” “pipeline,” “launch,” or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis 
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.

Disclosure: Dr. Tagawa is a paid consultant for Novartis.

References

On October 17, 2025, Ethereum (ETH), the world's second-largest cryptocurrency by market capitalization, experienced a notable downturn, trading near $3,870 after losing almost 4% intraday. The decline coincided with a broader cryptocurrency market correction, which saw over $100 billion wiped from the market in just three hours.

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

After one of the cruelest corrections of the year, Shiba Inu might be preparing for a resurgence. Following the crypto market crash, the meme token’s price recently added a zero. However, it now seems to be stabilizing, and if momentum continues, SHIB may be able to remove that zero in the coming days.

Shiba Inu market reversalIn an effort to create a base for a potential reversal, Shiba Inu has been consolidating closely near its local bottom, currently trading at about $0.0000098. The price action indicates that sellers are clearly exhausted, because there was a noticeable increase in buying volume following the large liquidation-driven decline that drove SHIB below $0.000010.

SHIB/USDT Chart by TradingViewDespite the high level of volatility, the last few sessions have shown smaller candles and less trading activity, which are typical indicators of market hesitancy prior to a breakout. Technically speaking, Shiba Inu has yet to regain any significant short-term bullish structure, as it continues to trade below all three major moving averages (the 50-, 100- and 200-day EMAs).

HOT Stories

Another push for SHIBNonetheless, the RSI’s proximity to 39 indicates that SHIB is approaching oversold territory, which is typically where price reversals take place. To push SHIB back above $0.000010 and remove the recently added zero, a clean breakout above the $0.0000112-$0.0000120 resistance zone would probably draw in new momentum traders and retail inflows.

For the next three days, volume confirmation is the most important thing to keep an eye on. A short-term rally may be in the works if trading volume rises and a green candle closes above $0.0000105, indicating that accumulation is taking place at current levels. Bullish sentiment may be strengthened by an increase in wallet activity or exchange outflows, according to on-chain data.

Journalist

Posted: October 19, 2025

Key Takeaways
What do the addresses depositing BTC signify?
The spike to 64k Active Addresses sending BTC to Binance on the 14th of October signified increased selling, but this number has begun to fall.

Is the short-term outlook bullish or bearish?
Based on the evidence at hand, the outlook remains bearish. There are clues of a bullish reversal, but traders need to wait a while before betting on a price recovery.

The number of Active Addresses sending Bitcoin [BTC] to Binance increased dramatically last week as BTC toppled from $121.5k to $102k within a day on Friday, the 10th of October.

Bitcoin inflows ease as volatility cools
According to CryptoQuant, between 54,300 and 57,780 unique addresses deposited BTC in the following days.

In fact, in a post on CryptoQuant Insights, analyst Darkfost noted that the 14th of October saw 64,000 unique addresses deposit Bitcoin.

The last time such heavy inflows were seen was in July, when BTC crossed the $120k mark.

This spike in Exchange Inflows pointed to panic-driven selling and short-term capitulation, deepening volatility as BTC slid under $108K.

However, on the 18th of October, the number of Active Addresses depositing Bitcoin reduced to 30,850. This gradual drop showed reduced selling pressure and suggested that the market could be finding its new equilibrium.

Decoding the short-term BTC expectations
Traders and investors should be careful of betting on a BTC bullish rebound. They should be doubly careful that they don’t bet on such a move early.

Because the Liquidation Heatmap of the past two weeks showed that the price compression of the past 36 hours saw liquidation levels build up at $108k and $106.2k.

On top of that, higher zones at $114K and $116.5K were filled with leveraged positions, making them potential magnet levels for price rebounds if BTC breaks above $108K.

Hence, traders would want to see a move beyond $108k, as this would increase the chances of further price moves higher to the liquidity clusters overhead.

A recent AMBCrypto report highlighted why a rally to $117k was possible.

Recently, there was a surge in China’s M2 money supply. It has a positive correlation with Bitcoin price movements, and the leading crypto could be a beneficiary once again.

The Spot ETF Flows were negative to close out the previous week, showing bearish sentiment. The ETF capital flow could help signal a potential change in public sentiment if it turns positive.

Akashnath S is a Senior Journalist and Technical Analysis expert at AMBCrypto. He specializes in dissecting price action, identifying key market trends through advanced chart patterns, and forecasting both short-term and long-term asset trajectories.
His distinct analytical method is grounded in his academic training as a Chemical Engineer. This background provides him with a systematic, process-oriented approach to market data, enabling him to analyze the complex dynamics of financial markets with precision and objectivity.
Having actively covered the cryptocurrency space since the landmark 2017 market cycle, Akashnath possesses years of experience navigating both bull and bear markets. This seasoned perspective is critical to his insightful reporting on market volatility and evolution.
As an active market participant, Akashnath enhances his analysis with crucial, hands-on experience. This practical application of his technical skills ensures his insights are not merely theoretical, but are also relevant and actionable for an audience looking to understand and navigate trading opportunities. He is dedicated to educating readers on the nuances of technical analysis, empowering them with the knowledge to make more informed financial decisions.

Solana strengthens its dominance with fast transactions, $5B annual fees, and over 1,000 full-time developers.

Izabela Anna2 min read

19 October 2025, 01:14 PM

Solana continues to solidify its dominance as a preferred blockchain for decentralized applications, with Grayscale’s latest report emphasizing its growing role in the global crypto ecosystem. 

The network has evolved into a central hosting platform for major decentralized projects like Raydium, Pump.fun, and Helium, attracting both developers and investors seeking scalable blockchain solutions. Its ability to process high transaction volumes at a low cost has become one of its defining strengths.

Expanding Ecosystem and Developer GrowthSource: X

The Solana ecosystem generates approximately $425 million in monthly fees, translating to more than $5 billion annually. This strong revenue base demonstrates the network’s growing on-chain activity and adoption. Unlike other blockchains facing congestion and high fees, Solana’s average transaction cost remains around $0.02, making it appealing for both users and developers.

Besides its economic performance, Solana’s human capital continues to grow. The network now has more than 1,000 full-time developers, second only to Ethereum. This expanding developer base is fostering rapid innovation, with projects spanning DeFi, consumer apps, and digital infrastructure. 

Raydium operates as a decentralized exchange on Solana, while Pump.fun has become a key platform for consumer-focused blockchain activity. Helium, another prominent project, utilizes Solana for mobile hotspot networks. Together, these applications illustrate Solana’s versatility and strong developer engagement.

Technical Strength and Investor AppealSolana’s technical design remains one of the fastest among smart contract blockchains. New blocks are produced every 400 milliseconds, and transactions reach finality within 13 seconds. 

This combination of speed and reliability enhances user experience and supports broader adoption across industries. Consequently, the network’s consistent performance has helped it stand out in an increasingly competitive landscape.

From an investment perspective, Solana’s tokenomics present an attractive balance between inflation and yield. The annual supply growth of SOL tokens stands between 4% and 4.5%, while staking rewards average about 7%. 

Source: X

Hence, investors who stake SOL earn real returns between 2.5% and 3%. These figures reflect a sustainable incentive model that encourages long-term participation in the network.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Izabela Anna

Izabela Anna is a knowledgeable freelance journalist, who boasts over five years of experience covering the cryptocurrency market. Her tenure has seen her navigate through the ebbs and flows of multiple market cycles, giving her a deep understanding within. Her journalistic focus lies in dissecting price action dynamics, scrutinizing the on-chain landscape, and providing insights from a technical perspective, making her a trusted voice in the realm of cryptocurrency reporting.

Read more about

Latest Solana (SOL) News Today

The weekend was buzzing with significant developments in the cryptocurrency world. From Ripple Labs’ ambitious $1 billion fundraising initiative to bold Bitcoin predictions by Mexico’s third-richest person and a crypto-focused political agenda, the crypto space continues to evolve at a rapid pace.

Here’s a quick recap of the top stories.

Ripple Labs Spearheads $1 Billion FundraiseBlockchain firm Ripple Labs is reportedly leading a $1 billion fundraising effort to establish a treasury focused on XRP. The funds, to be raised via a special purpose acquisition company, will be transferred to a newly formed digital-asset treasury. Ripple Labs will also contribute some of its own XRP to the treasury.

Read the full article here.

Bitcoin To Outperform Gold, Predicts Mexico’s Third Richest PersonRicardo Salinas Pliego, Mexico’s third-richest person, has made a bold prediction that Bitcoin will increase by at least fourteen times and ultimately surpass gold in value. Salinas made this forecast in response to gold’s historic achievement of reaching a market capitalization of $30 trillion.

Read the full article here.

See Also: XRP Awaits ETF Decisions: Is A Push To $3 Coming?

Tom Lee And Arthur Hayes Remain Bullish On Bitcoin, EthereumTom Lee, chair of BitMine Immersion Technologies Inc, and BitMEX co-founder Arthur Hayes have reiterated their bullish year-end targets for Bitcoin and Ethereum. They highlighted Bitcoin’s recent all-time highs and discussed the market dynamics in a recent episode of the Bankless podcast.

Read the full article here.

Peter Schiff Warns Of Imminent Bitcoin, Ethereum CrashVeteran gold advocate Peter Schiff has warned of an impending collapse across the broader crypto market as Bitcoin broke to $106,000. Schiff noted that Bitcoin has lost 34% of its value relative to gold since its August all-time high, suggesting a potential deepening of the downtrend.

Read the full article here.

Donald Trump And Nigel Farage: The New Crypto Champions?The race for crypto dominance has entered politics, with U.S. President Donald Trump and Reform U.K.'s leader Nigel Farage both pitching bold visions to make their nations the global hub for digital assets. Farage outlined plans to create a "state-owned Bitcoin reserve" and introduce a new crypto bill to cut capital gains tax and allow taxes to be paid in digital assets.

Read the full article here.

Read Next:

Trump Family Reportedly Makes $1 Billion In Profit From Crypto Ventures
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Image via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

NewsPricesResearchEventsData & IndicesSponsoredSign InSign UpDOGE Holds $0.19 Base as 'Smart Money' Accumulates Ahead of Breakout AttemptTraders focus on a potential breakout above $0.192 to sustain upward momentum.Updated Oct 19, 2025, 1:33 p.m. Published Oct 19, 2025, 1:33 p.m.

(CoinDesk Data)

What to know: DOGE stabilizes after a volatile week, with institutional interest driving a rebound.The meme token sees a 3% increase, trading between $0.186 and $0.191.Traders focus on a potential breakout above $0.192 to sustain upward momentum.DOGE steadies after a volatile week, grinding higher through Friday as desks see renewed interest from institutional and corporate wallets. Volumes remain heavy, but the tape looks cleaner — buyers defending the $0.188 base with conviction. Traders say positioning is quietly turning constructive into the weekend.

News BackgroundDOGE’s rebound comes as broader risk assets stabilize following heavy midweek liquidations. The meme token added roughly 3% in the 24 hours to October 19 08:00, trading from $0.186 lows to a $0.191 peak. Market chatter points to new inflows tied to treasury allocation pilots following House of Doge’s Nasdaq debut, drawing early corporate curiosity into crypto balance-sheet exposure.Institutional desks flagged a breakout around 17:00 UTC on Thursday as DOGE ripped from $0.187 to $0.191 on 276 million in volume — four times its average. That impulse marked the first convincing high-volume bid since last week’s trade-war flush and defined $0.188 as new support.Price Action SummaryDOGE’s 24-hour range hit roughly 3% between $0.186–$0.191, with bulls maintaining control through the U.S. session. Price action flattened into late Asia hours, with volume tapering — a classic sign of passive accumulation rather than forced liquidation. The final hour saw a brief dip to $0.188 before a snap recovery through $0.190 on a burst of 8.7 million in volume, confirming interest from algorithmic buyers defending the line.Technical AnalysisPrice structure stays constructive above $0.188. Momentum bias turns positive as funding normalizes and short exposure clears. A decisive push through $0.192 opens the path toward $0.197–$0.200 — the upper boundary of last week’s distribution zone.Failure to hold $0.188 would re-expose $0.182–$0.180 supports, but flow data suggest bids remain firm below spot.What Traders Are WatchingTraders are eyeing a clean break through $0.192 to confirm continuation. On-chain trackers show moderate whale inflows resuming after early-month distribution. Treasury desk activity remains the wildcard — any follow-through from corporate accumulation could turn this into a sustained base rather than a dead-cat bounce.Mais para você

Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent.

View Full Report

More For You

Bitcoin’s Bullish October Is Headed to Be its Worst in 10 Years

The historical average for October sits around 19.8%, next to November's 42% which is the asset's strongest month.

What to know:

Bitcoin is experiencing its worst October since 2015, with a 5% decline so far.Macro risks, including the U.S.–China tariff standoff, have overshadowed the usual October rallies.Despite the downturn, there is still potential for a late-month recovery, as seen in past years.Read full story

Florida is taking bold steps to integrate Bitcoin into state-managed funds, potentially making it one of the first U.S. states to adopt digital assets as part of its public investment strategy. Lawmakers introduced House Bill 183 (HB 183) on October 15, 2025, which proposes that the state's Chief Financial Officer (CFO) can allocate up to 10% of specific state funds, including the General Revenue Fund and the Budget Stabilization Fund, into Bitcoin and other digital assets.

Journalist

Posted: October 19, 2025

Key Takeaways
Who bore the brunt of the Bitcoin DAT bubble burst?
Retail investors, who lost an estimated $17 billion after buying shares in MSTR, Metaplanet, and other Bitcoin DAT firms at inflated prices.

What’s the broader impact on BTC treasuries?
Overvalued DATs labeled as “bubbles” have begun to burst, putting Bitcoin’s institutional credibility at risk.

On paper, more and more companies adding Bitcoin [BTC] to their treasuries looks like a big win for investors, showing that BTC is being taken seriously as a “store of value” by institutions.

As evidence, Bitwise used hard data to highlight this trend.

During Q3, the number of corporate Bitcoin holders rose 38% to 172, as 48 new companies joined the club. Together, these companies purchased 176,000 BTC, bringing the total corporate stash to just over 1 million BTC.

Strategy leads corporate holdings

Source: BitcoinTreasuries.net

Focusing on the top holders, Strategy [MSTR] stood out, with over 640,000 BTC in its treasury. Technically, that’s nearly 13 times the size of MARA Holdings [MARA], the second-largest corporate holder.

On paper, MSTR’s Bitcoin-focused strategy appeared to have delivered performance that even outpaces the “Magnificent 7” stocks in annualized return, highlighting the effectiveness of its corporate treasury approach.

That said, some analysts are raising caution. 

Tom Lee, Chairman of BitMine, warned that the growing bubble in DATs (Digital Asset Treasuries) “may already have burst.” If so, could Bitcoin’s biggest institutional dream now be spiraling toward its biggest nightmare?

$17B in losses shine spotlight on Bitcoin’s DAT fragility
Is the age of financial magic ending for Bitcoin treasury companies?

According to a recent report by 10x Research, the reality may be tougher than most investors think.

Specifically, retail investors have collectively lost an estimated $17 billion by gaining exposure to BTC through DAT firms.

The report spotlighted how these firms sold shares at premiums.

For example, investors buying into MSTR or Metaplanet at high premiums lost money when share prices fell, leading to big losses for retail investors.

Source: 10x Research

As the chart showed, during the “boom” phase, Metaplanet looked very profitable on paper because its shares were sold far above the actual value of the Bitcoin it held, and investor hype drove buying at inflated prices.

However, when the “bust” hit, share prices corrected sharply, and the Net Asset Value (NAV) of these treasuries dropped, leaving investors facing real losses instead of the inflated gains they had expected.

So, while executives walked away with profits, investors bore the brunt. 

Overall, these overvalued DATs, labeled as “bubbles,” have begun to burst, putting BTC’s institutional credibility at risk. Investors are now rethinking their exposure to them, marking the potential start of their decline.

Ritika Gupta is a Financial Journalist and Geopolitical Analyst at AMBCrypto, specializing in the critical intersection of world politics, economic policy, and the cryptocurrency markets. Her analysis is informed by her distinguished background, which includes professional experience at major news network.
She holds a Bachelor's degree in Political Science and Psychology from Gargi College, University of Delhi. This academic training provides her with a sophisticated framework for dissecting complex issues such as international regulations, government fiscal policies, and the geopolitical forces that directly influence asset valuations.
At AMBCrypto, Ritika applies this expert lens to synthesize macroeconomic data and political developments, offering readers a deeper context for market movements. She excels at explaining not just what is happening in the market, but why it is happening. Her work is dedicated to providing strategic insights that empower readers to understand the complex relationship between global events and their digital assets.